v3.26.3
Investments in and Advances to Joint Ventures (Tables)
9 Months Ended
Sep. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

 

 

 

September 30, 2026

 

 

December 31, 2025

 

Current assets

 

$

480,003

 

 

$

542,877

 

Noncurrent assets

 

 

6,305

 

 

 

7,961

 

Total assets

 

 

486,308

 

 

 

550,838

 

Current liabilities

 

 

269,649

 

 

 

301,891

 

Noncurrent liabilities

 

 

3,076

 

 

 

3,417

 

Total liabilities

 

 

272,725

 

 

 

305,308

 

Total joint venture equity

 

$

213,583

 

 

$

245,530

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Revenue

 

$

198,691

 

 

$

213,752

 

 

$

577,638

 

 

$

602,905

 

Costs

 

 

172,046

 

 

 

178,123

 

 

 

496,643

 

 

 

505,145

 

Net income

 

$

26,645

 

 

$

35,629

 

 

$

80,995

 

 

$

97,760

 

Net income attributable to noncontrolling interests

 

$

13,258

 

 

$

17,671

 

 

$

40,297

 

 

$

48,514

 

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

 

 

 

September 30, 2026

 

 

December 31, 2025

 

Current assets

 

$

1,373,495

 

 

$

1,549,367

 

Noncurrent assets

 

 

411,609

 

 

 

439,496

 

Total assets

 

 

1,785,104

 

 

 

1,988,863

 

Current liabilities

 

 

843,237

 

 

 

1,046,970

 

Noncurrent liabilities

 

 

458,554

 

 

 

469,833

 

Total liabilities

 

 

1,301,791

 

 

 

1,516,803

 

Total joint venture equity

 

$

483,313

 

 

$

472,060

 

Investments in and advances to unconsolidated joint ventures

 

$

174,764

 

 

$

148,640

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Revenue

 

$

599,294

 

 

$

608,305

 

 

$

1,331,238

 

 

$

1,558,656

 

Costs

 

 

551,887

 

 

 

563,832

 

 

 

1,318,855

 

 

 

1,476,009

 

Net income

 

$

47,407

 

 

$

44,473

 

 

$

12,383

 

 

$

82,647

 

Equity in earnings of unconsolidated joint ventures

 

$

7,242

 

 

$

8,266

 

 

$

(20,350

)

 

$

6,937

 

Summary of Financial Statement Impact From Changes In Estimates on an Unconsolidated Joint Venture

The following table presents certain financial statement impacts from changes in estimates on an unconsolidated joint venture in the Critical Infrastructure segment, driven by increases in costs to complete. In certain instances, revisions in estimates on unconsolidated joint ventures do not exceed the threshold in any particular quarter but exceed the threshold on a year-to-date basis (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Operating loss

 

$

-

 

 

$

-

 

 

$

(40,854

)

 

$

(14,478

)

Net loss

 

 

-

 

 

 

-

 

 

 

(35,053

)

 

 

(10,869

)

Diluted loss per share

 

$

-

 

 

$

-

 

 

$

(0.33

)

 

$

(0.10

)